EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Pharmacology and relevant drug interactions of metamizole

David J Brinkman iD, Linda C Hendriksen, Irma M Rigter, Markus W Hollmann

British Journal of Clinical Pharmacology · 2025-07 · 91 (7) · 2095-2102

DOI: 10.1002/bcp.70101 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 15.05.2025. Verfasst von David J Brinkman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Amsterdam UMC, Amsterdam, Netherlands. Hauptthemen laut MEDLINE: Dipyrone, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metamizole is a frequently prescribed analgesic because of its favourable benefit/risk ratio compared with classic NSAIDs. However, increasing research shows that metamizole displays several drug interactions that are relevant to clinical practice. We reviewed the literature to summarize the pharmacology and most clinically relevant drug interactions of metamizole. Metamizole has a fast analgesic effect but a short half‐life and duration of action. The exact mechanism of action of metamizole is currently not fully known. Studies showed that metamizole appears to be a moderate to strong inductor of the enzymes CYP3A4, CYP2B6 and CYP2C19; a weak inductor of CYP2C9; and a moderate inhibitor of CYP1A2. Furthermore, metamizole inhibits the effect of acetylsalicylic acid when taken simultaneously. Metamizole should be cautiously used together with other drugs that can cause agranulocytosis. If metamizole is prescribed in a high dosage (1000 mg three or four times daily) for more than 1 day, these pharmacokinetic and dynamic interactions should be taken into account.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipyroneAnti-Inflammatory Agents, Non-SteroidalHumansDrug InteractionsCytochrome P-450 Enzyme SystemAspirin

Stichwörter der Autor:innen

CYPacetylsalicylic aciddipyroneinteractionsmetamizolepharmacology

Substanzen

DipyroneAnti-Inflammatory Agents, Non-SteroidalCytochrome P-450 Enzyme SystemAspirin

Autor:innen und Institutionen

  • Department of Anaesthesiology, Amsterdam UMC, Amsterdam, Netherlands.
  • Department of Internal Medicine, Pharmacotherapy Unit, Amsterdam UMC, Amsterdam, Netherlands.
  • Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, Netherlands.
  • Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Amsterdam, Netherlands.

ORCID-Profile: David J Brinkman

Zitieren

APA

Brinkman, D. J., Hendriksen, L. C., Rigter, I. M., & Hollmann, M. W. (2025). Pharmacology and relevant drug interactions of metamizole. British Journal of Clinical Pharmacology, 91(7), 2095-2102. https://doi.org/10.1002/bcp.70101

Vancouver

Brinkman DJ, Hendriksen LC, Rigter IM, Hollmann MW. Pharmacology and relevant drug interactions of metamizole. British Journal of Clinical Pharmacology. 2025;91(7):2095-2102. doi:10.1002/bcp.70101

BibTeX
@article{Brinkman2025,
  author = {Brinkman, David J and Hendriksen, Linda C and Rigter, Irma M and Hollmann, Markus W},
  title = {Pharmacology and relevant drug interactions of metamizole},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  volume = {91},
  number = {7},
  pages = {2095--2102},
  doi = {10.1002/bcp.70101}
}
Kostenlos starten →